Uhmontpellier
Montpellier, 34290, France
NCT Number: NCT04820140
Aim of this study is to evaluate, in a population of chronic kidney disease patients on dialysis (Stage 5D), the effect of a muscle strengthening program (training against resistance vs endurance training by elliptical bike) during a observational period (12 weeks per program) on frailty, risk of falling, muscle strength and mass, endurance, physical activity, quality of dialysis, nutritional status and neuromuscular sensitivity.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, 34290, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lymphatic drainage
Time frame: 4 weeks after inclusion
Change in functional autonomy (frailty) after training
Time frame: 12 weeks after inclusion
Change in functional autonomy (frailty) after training
Time frame: 16 weeks after inclusion
Change in functional autonomy (frailty) after training and endurance training by elliptical bike during an observational period (12 weeks per program).
Time frame: 32 weeks after inclusion
Change in functional autonomy (frailty) after training and endurance training by elliptical bike during an observational period (12 weeks per program).
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in risk of falling after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in muscle strength and mass after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in endurance after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in physical activity after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in quality of dialysis after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in nutritional status after training
Time frame: 4, 12, 16 and 32 weeks after inclusion
Change in neuromuscular sensitivity after training
Looking for future studies?
Notify MeUniversity Hospital, Montpellier
Other
Acronym: REHABIMUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04392440
Chronic Disease, Chronic Kidney Diseases
Rochester, New York, United States
View Trial DetailsNCT07058909
Acute Kidney Injury, Acute Renal Failure
Norfolk, Virginia, United States
View Trial DetailsNCT04910867
Apolipoprotein L1, Chronic Disease
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06332469
Chronic Disease, Chronic Kidney Diseases
Norrköping, Sweden
View Trial Details